The therapeutic effect of anti-CD52 treatment in murine experimental autoimmune encephalomyelitis is associated with altered IL-33 and ST2 expression levels.

Saved in:
Bibliographic Details
Title: The therapeutic effect of anti-CD52 treatment in murine experimental autoimmune encephalomyelitis is associated with altered IL-33 and ST2 expression levels.
Authors: Barbour, Mark1, Wood, Rachel1, Hridi, Shehla U.1, Wilson, Chelsey1, McKay, Grant1, Bushell, Trevor J.1, Jiang, Hui-Rong1 huirong.jiang@strath.ac.uk
Source: Journal of Neuroimmunology. May2018, Vol. 318, p87-96. 10p.
Database: Academic Search Ultimate
Description
ISSN:01655728
DOI:10.1016/j.jneuroim.2018.02.012